Drug application
SUMATRIPTAN SUCCINATE (AUTOINJECTOR) (SUMATRIPTAN SUCCINATE)
Drugs@FDA ANDA 213518 · ALEMBIC
Key facts
| Drug name | SUMATRIPTAN SUCCINATE (AUTOINJECTOR) |
|---|---|
| Active ingredients | SUMATRIPTAN SUCCINATE |
| Application type | ANDA |
| Application number | 213518 |
| Company | ALEMBIC |
| Dosage forms | SOLUTION, SUBCUTANEOUS |
| Strength | EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Nov 6, 2025 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.